HRT and prevention of coronary heart disease
Coronary heart disease (CHD) is a major disease for women. This talk outlines the effects of menopause on coronary heart disease (CHD), focusing on the metabolic risk factors and the direct arterial effects.
Professor John Stevenson provides evidence that HRT is effective for the primary prevention of CHD in postmenopausal women.
- Understand the metabolic risk factors for CHD
- Review the direct arterial effects of HRT
- Review the different effects of different HRT preparations
- Learn the importance of the dose at initiation of therapy, the route of administration, and the timing of the intervention
Professor John Stevenson is a consultant physician and endocrinologist at Royal Brompton Hospital. He specialises in metabolic disorders, coronary disease prevention, bone disease and calcium metabolism and general endocrinology.
In 1993, Professor Stevenson jointly established the UK’s first female heart disease clinic at Royal Brompton Hospital, and he currently runs heart risk clinics at Royal Brompton Hospital.
Learn more about Professor John Stevenson, his clinical interests, publications and teaching here.
Would you like to know more?
Please get in touch with our team who will be able to assist you.